Dear Readers, As we step into the 10th year of publication of ACS Infectious Diseases, it is with great enthusiasm that I share with you some pivotal developments related to our journal. In response to the ever-expanding landscape of infectious diseases research, we have undertaken an initiative to broaden our scope, to encompass a wide spectrum of topics. In addition to the existing themes of the scope, our journal now also welcomes manuscripts that explore diverse aspects of infectious diseases, ranging from chemistry-driven immunomodulatory therapeutics to host-directed antimicrobial therapeutics, novel biomaterials mitigating infections, mechanistic understanding of inflammation and infection interplay, and host–microbiome and pathogen interactions within the context of infection, immunity, and inflammation. This expansion is an earnest attempt toward encouraging contributions from researchers across various disciplines, facilitating a collaborative environment where diverse perspectives converge to address the complex challenges posed by infectious diseases. The hope is to provide a comprehensive and interdisciplinary perspective on infectious diseases, encouraging contributions that bridge traditional boundaries and push the frontiers of knowledge. In alignment with our renewed focus, I am pleased to introduce two esteemed colleagues who have joined our Editorial Board. Prof. Mark Brönstrup, an accomplished researcher from the Helmholtz Centre for Infection Research in Germany, assumes the role of Associate Editor. He currently leads the Chemical Biology department at his institute. Prof. Brönstrup has a diverse portfolio in infectious disease research, encompassing therapeutics, mechanism of action studies, diagnostics, and host–pathogen interactions through omics studies. His research primarily targets bacterial and viral pathogens, drawing from his experience in both industry and academia. Additionally, we welcome Prof. Yuan Qiao from Nanyang Technological University (NTU) in Singapore as our new Topic Editor. Dr. Qiao, an Assistant Professor at NTU, investigates the molecular signals used by gut microbiota to communicate with the host, aiming to understand the mechanisms underlying microbiota-related diseases. She also develops chemical approaches to profile and characterize microbiota-derived signaling molecules involved in bacteria–host crosstalk, primarily focusing on bacterial and fungal pathogens. Concurrently, as part of our commitment to expanding the scope and inclusivity of ACS Infectious Diseases, we are delighted to announce the reorganization of our Editorial Advisory Board (EAB). The EAB now mirrors the expansive range of topics within the journal, featuring representation from various research areas. Our EAB members proudly represent 15 different nationalities, across six continents, reflecting in a way the global collaboration that is essential for tackling infectious diseases on a broader scale. Furthermore, we are excited to announce the establishment of an Early Career Board (ECB) at ACS Infectious Diseases. This initiative aims to provide a platform for young researchers from different backgrounds, and currently 12 different nationalities, promoting inclusivity and innovation in the field of infectious diseases. I take this opportunity to reiterate our commitment to build a collaborative community that thrives on diverse perspectives. We invite all of you to be part of this exciting journey, contributing your research to a journal that embraces the complexity of infectious diseases and values the richness that diverse viewpoints bring to scientific discourse. I am looking forward to continued support and engagement of the infectious diseases research community with ACS Infectious Diseases. This article has not yet been cited by other publications.

中文翻译：

---

ACS 传染病期刊范围、编辑团队和顾问委员会成员的最新动态

尊敬的读者，在《ACS 传染病》出版第十周年之际，我怀着极大的热情与您分享与我们期刊相关的一些关键进展。为了应对不断扩大的传染病研究领域，我们采取了一项举措来扩大我们的范围，以涵盖广泛的主题。除了该范围的现有主题外，我们的期刊现在还欢迎探索传染病各个方面的手稿，从化学驱动的免疫调节疗法到宿主导向的抗菌疗法、减轻感染的新型生物材料、炎症和感染相互作用的机制理解，以及感染、免疫和炎症背景下宿主-微生物组和病原体的相互作用。此次扩展是一次真诚的尝试，旨在鼓励不同学科的研究人员做出贡献，促进不同观点汇聚的协作环境，以应对传染病带来的复杂挑战。希望提供关于传染病的全面和跨学科的视角，鼓励弥合传统界限并推动知识前沿的贡献。为了配合我们新的重点，我很高兴地介绍两位尊敬的同事加入我们的编辑委员会。德国亥姆霍兹感染研究中心的资深研究员 Mark Brönstrup 教授担任副主编。他目前领导其研究所的化学生物学系。 Brönstrup 教授在传染病研究方面拥有丰富的经验，包括治疗学、作用机制研究、诊断以及通过组学研究进行的宿主与病原体相互作用。他的研究主要针对细菌和病毒病原体，借鉴了他在工业界和学术界的经验。此外，我们还欢迎新加坡南洋理工大学 (NTU) 的乔远教授担任我们的新主题编辑。乔博士是南洋理工大学的助理教授，研究肠道微生物群与宿主沟通的分子信号，旨在了解微生物群相关疾病的机制。她还开发了化学方法来分析和表征参与细菌-宿主串扰的微生物群衍生信号分子，主要关注细菌和真菌病原体。同时，作为我们扩大ACS 传染病范围和包容性承诺的一部分，我们很高兴地宣布重组我们的编辑顾问委员会 (EAB)。 EAB 现在反映了期刊内广泛的主题，具有各个研究领域的代表性。我们的 EAB 成员自豪地代表来自六大洲 15 个不同国家的成员，这在某种程度上反映了对于更广泛地应对传染病至关重要的全球合作。此外，我们很高兴地宣布ACS 传染病中心成立了早期职业委员会 (ECB) 。该倡议旨在为来自不同背景、目前来自12个不同国家的年轻研究人员提供一个平台，促进传染病领域的包容性和创新。我借此机会重申我们致力于建立一个在多元化观点下蓬勃发展的协作社区。我们邀请大家加入这一激动人心的旅程，将您的研究贡献给一本涵盖传染病复杂性并重视不同观点为科学话语带来的丰富性的期刊。我期待传染病研究界继续支持ACS 传染病并参与其中。这篇文章尚未被其他出版物引用。